摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5,7,10,12,14,17,19,21,24,26,28-dodecamethyl[1.1.1.1]metacyclophane-4,11,18,25-tetrol | 145572-23-2

中文名称
——
中文别名
——
英文名称
3,5,7,10,12,14,17,19,21,24,26,28-dodecamethyl[1.1.1.1]metacyclophane-4,11,18,25-tetrol
英文别名
4,6,10,12,16,18,22,24,25,26,27,28-dodecamethylpentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaene-5,11,17,23-tetrol
3,5,7,10,12,14,17,19,21,24,26,28-dodecamethyl[1.1.1.1]metacyclophane-4,11,18,25-tetrol化学式
CAS
145572-23-2
化学式
C40H48O4
mdl
——
分子量
592.819
InChiKey
WAKLCZAHNJRGDW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    310 °C
  • 密度:
    1.137±0.06 g/cm3(Predicted)
  • 稳定性/保质期:
    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    10.6
  • 重原子数:
    44
  • 可旋转键数:
    0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    80.9
  • 氢给体数:
    4
  • 氢受体数:
    4

SDS

SDS:0f7254082a102eea13d5c6d7df4f5009
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,5,7,10,12,14,17,19,21,24,26,28-dodecamethyl[1.1.1.1]metacyclophane-4,11,18,25-tetrolsodium hydroxide氯化亚砜potassium carbonate三乙胺 作用下, 以 四氢呋喃乙醇丙酮 为溶剂, 反应 12.0h, 生成 2-[[4,6,10,12,16,18,22,24,25,26,27,28-dodecamethyl-11,17,23-tris[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethoxy]-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaenyl]oxy]-N-[(1S)-1-phenylethyl]acetamide
    参考文献:
    名称:
    Informational rigidity in mesitylene-based calix[4]arenes adopting a 1,3-alternate conformation
    摘要:
    Two chiral derivatives of a mesitylene-based calix[4]arene known to exist in the 1,3-alternate conformation were prepared by the attachment of homochiral residues to the four exo-hydroxy groups. Thus, the enantiotopic protons of the central scaffold became diastereotopic, leading to a doubling of their H-1 NMR signals in one example. From the temperature independence of the NR IR spectrum, a lower limit of 24.2 kcal/mol could be estimated for the barrier of ring inversion. MM3 calculations confirm the 1,3-alternate conformation as the energy minimum, and estimate a barrier of 25.7 kcal/mol for the 1,3-alternate-to-1,3-alternate* interconversion process. This high barrier is due to the repulsive steric interactions between exo-methyl groups at vicinal rings when these groups pass each other. (C), 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0957-4166(00)00177-4
  • 作为产物:
    参考文献:
    名称:
    1,3-交替四巯基[1.1.1.1]间环phane的合成
    摘要:
    1,3-交替3,5,7,10,12,14,17,19,21,24,26,28-十二烷基甲基[1.1.1.1]间环phane-4,11,18,25-四硫醇的制备方法从四羟基间环己烯开始,分三步收率。
    DOI:
    10.1016/s0040-4039(00)61465-x
点击查看最新优质反应信息

文献信息

  • Sensing and Fixation of NO<sub>2</sub>/N<sub>2</sub>O<sub>4</sub> by Calix[4]Arenes
    作者:Grigory V. Zyryanov、Yanlong Kang、Dmitry M. Rudkevich
    DOI:10.1021/ja029166l
    日期:2003.3.1
    NO(+) is found encapsulated within the calixarene cavity, and stable charge-transfer complexes result with K(ass) > 10(6) M(-1) (CDCl(3)). The NO(+) encapsulation was also demonstrated in titration experiments with calixarenes 1, 2, and 5 and commercially available NO(+)SbF(6)(-) salt in chloroform. The complexation process is reversible, and the complexes dissociate upon addition of water and alcohol
    提出了一种对 NO(2)/N(2)O(4) 进行视觉检测和化学利用的方法,该方法采用简单的杯 [4] 芳烃。四-O-烷基化杯[4]芳烃 1 和 2,具有锥形或 1,3-交替构象,暴露于 NO(2)/N(2)O(4),无论是在氯仿溶液中还是在氯仿溶液中固态,产生深颜色的杯芳烃-亚硝基鎓 (NO(+)) 络合物。在路易斯酸的存在下,如 SnCl(4),稳定的杯芳烃-NO(+) 配合物 7 和 8 以定量产率分离出来,并通过紫外-可见光、FTIR、高分辨率 (1) H NMR 光谱表征和元素分析。NO(+) 被发现封装在杯芳烃腔内,稳定的电荷转移复合物导致 K(ass) > 10(6) M(-1) (CDCl(3))。NO(+) 包封也在杯芳烃 1、2、和 5 和市售的 NO(+)SbF(6)(-) 盐在氯仿中。络合过程是可逆的,加入水和醇后,络合物解离,回收母体杯芳烃。展示了功能化杯[4] 芳烃与硅胶的连接,这提供了一种固体材料
  • Molecular tectonics: on the formation of tubular coordination networks
    作者:Guillaume Laugel、Ernest Graf、Mir Wais Hosseini、Jean-Marc Planeix、Nathalie Kyritsakas
    DOI:10.1039/b607982m
    日期:——
    Upon combining the organic tecton based on the [1,1,1,1]metacyclophane bearing four pyridine groups with silver cation, a tubular coordination network formed by double bridging of consecutive macrocycles by metal centres is obtained and structurally characterised in the solid state by an X-ray diffraction method. The same tecton when combined with HgCl2 leads to the formation of a doubly interpenetrated 2-D coordination framework.
    将基于[1,1,1,1]四吡啶基元有机结构与银阳离子结合,通过金属中心双桥接连续大环形成管状配位网络,并通过X射线衍射方法在固态下进行结构表征。当该有机结构与HgCl2结合时,形成双互穿二维配位框架。
  • Synthesis and solid state structural analysis exo-bisbidentate ligands based on [1.1.1.1]metacyclophane in 1,3-alternate conformation bearing 2,2′-bipyridine or bisquinoline chelates
    作者:Cédric Klein、Ernest Graf、Mir Wais Hosseini、Gilles Mislin、André De Cian
    DOI:10.1016/s0040-4039(00)01647-6
    日期:2000.11
    The synthesis and structural analysis of two new exoligands 1 and 2 based on a [1.1.1.1]-metacyclophane backbone bearing either 2,2'-bipyridine or bisquinoline chelating units have been achieved. (C) 2000 Elsevier Science Ltd. All rights reserved.
  • Covalently linked multi-calixarenes
    作者:O. Mogck、P. Parzuchowski、M. Nissinen、V. Böhmer、G. Rokicki、K. Rissanen
    DOI:10.1016/s0040-4020(98)00594-8
    日期:1998.8
    ipso-Nitration of t-butyl calix[4]arene tetraethers and subsequent hydrogenation provides an easy access to monoamino calix[4]arenes. Reaction with di- and triacid chlorides leads to various double- and triple-calix[4]arenes. With tetra-acid chlorides derived from calix[4]arenes in the cone- or 1,3-alternate-conformations penta-calix[4]arenes are available as molecularly uniform species, which may be regarded as the first generation of calix[4]arene based dendrimers. The structure of the mononitro tetraester derivative, which may serve as a general building block has been confirmed by single crystal X-ray analysis. (C) 1998 Elsevier Science Ltd. All rights reserved.
  • Mesitylene-derived 1,3-alternate [1.1.1.1]metacyclophanes
    作者:Sebastiano Pappalardo、George Ferguson、John F. Gallagher
    DOI:10.1021/jo00052a023
    日期:1992.12
    Synthetic procedures to conformationally immobile 1,3-alternate [1.1.1.1]metacyclophanes based on mesitylene units are described. Coupling of mesitol (19) with bis(chloromethyl)mesitol (20) and bis(chloromethyl)mesitylene (21) in nitroethane in the presence of SnCl4 affords metacyclophanes 6 and 7-10, respectively, possessing extra-annular hydroxyl groups. Metacyclophanes 12 and 14, which hold one or two pairs of carboxyl groups in the distal positions, have been obtained from the appropriate distal diol 8 and tetrol 6 by treatment with tert-butyl bromoacetate followed by basic hydrolysis. Functionalized molecular frameworks, such as 15 and 18, have been also prepared in high yield by direct methods. The H-1 NMR spectral characteristics of 1,3-alternate metacyclophanes synthesized are briefly discussed. The structures of mono-, tri-, and tetrahydroxy metacyclophanes 10, 7, and 6, respectively, have been determined by X-ray crystallography. All three macrocycles have very similar 1,3-alternate-biconic conformations with approximate 42mBAR symmetry. Molecules 10 and 7 are isomorphous, and the lone hydroxyl group in 10 and the three hydroxyl groups in 7 are disordered over four possible sites. A toluene of solvation is docked against the molecular cavity in both 10 and 7. Compound 6 has crystallographic 2-fold symmetry and what would have been voids in the crystal lattice are occupied by disordered solvent molecules.
查看更多

同类化合物

2,9-二(2-苯乙基)蒽并[2,1,9-DEF:6,5,10-D’E’F’]二异喹啉-1,3,8,10(2H,9H)-四酮 (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-盐酸沙丁胺醇 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3,3''-双([[1,1''-联苯]-4-基)-[1,1''-联萘]-2,2''-二醇 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3S,3aR)-2-(3-氯-4-氰基苯基)-3-环戊基-3,3a,4,5-四氢-2H-苯并[g]吲唑-7-羧酸 (3R,3’’R,4S,4’’S,11bS,11’’bS)-(+)-4,4’’-二叔丁基-4,4’’,5,5’’-四氢-3,3’’-联-3H-二萘酚[2,1-c:1’’,2’’-e]膦(S)-BINAPINE (3-三苯基甲氨基甲基)吡啶 (3-[(E)-1-氰基-2-乙氧基-2-hydroxyethenyl]-1-氧代-1H-茚-2-甲酰胺) (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-硝基苯基)磷酸三酰胺 (2-氯-6-羟基苯基)硼酸 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1α,1'R,4β)-4-甲氧基-5''-甲基-6'-[5-(1-丙炔基-1)-3-吡啶基]双螺[环己烷-1,2'-[2H]indene (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1R,1′R,2S,2′S)-2,2′-二叔丁基-2,3,2′,3′-四氢-1H,1′H-(1,1′)二异磷哚